Editing 2C-B (section)

==Effects==
[[Image:2cb pill.jpg|thumb|right|2C-B pill with [[heart (symbol)|heart]] logo]]

Little academic research has been conducted on the effects of 2C-B in humans. The information available is largely [[Anecdotal evidence|anecdotal]] and limited. Effects are often described as being more easily managed than other psychedelics;<ref name="erowid basics">{{cite web | url = http://www.erowid.org/chemicals/2cb/2cb_basics.shtml | title = Erowid 2C-B Vault: Basics | access-date = 2013-09-25 | date = 2011-02-20 | publisher = [[Erowid]]}}</ref><ref name="PalamarAcosta2020">{{cite journal | vauthors = Palamar JJ, Acosta P | title = A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines | journal = Human Psychopharmacology | volume = 35 | issue = 1 | pages = e2719 | date = January 2020 | pmid = 31909513 | pmc = 6995261 | doi = 10.1002/hup.2719 }}</ref> it is often compared to a mixture of a [[serotonergic psychedelic]] and [[MDMA]].<ref name="Spain study">{{cite journal |vauthors=Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC |date=July 2012 |title=4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects |journal=Journal of Psychopharmacology |volume=26 |issue=7 |pages=1026–35 |doi=10.1177/0269881111431752 |pmid=22234927 |s2cid=35535891}}</ref> At 5–10&nbsp;mg, experiments with young chickens have shown it to produce effects similar to a low dosage of [[amphetamine]]s.<ref>{{cite journal | vauthors = Bronson ME, Jiang W, DeRuiter J, Clark CR | title = A behavioral comparison of Nexus, cathinone, BDB, and MDA | journal = Pharmacology, Biochemistry, and Behavior | volume = 51 | issue = 2–3 | pages = 473–475 | year = 1995 | pmid = 7667371 | doi = 10.1016/0091-3057(95)00013-M | s2cid = 32246652 }}</ref>

The anecdotal effects of 2C-B that have been reported by users on online discussion forums include:<ref name="erowid effects">{{cite web | url = http://www.erowid.org/chemicals/2cb/2cb_effects.shtml | title = Erowid 2C-B Vault: Effects | access-date = 2013-09-25 | publisher = [[Erowid]]}}</ref><ref name="Drugscope">{{cite web | url = http://www.drugscope.org.uk/resources/drugsearch/drugsearchpages | title = Drugscope: 2C-B | access-date = 2013-09-25 | date = Jan 2004 | publisher = [[Drugscope]] | archive-url = https://web.archive.org/web/20130928055351/http://www.drugscope.org.uk/resources/drugsearch/drugsearchpages | archive-date = 2013-09-28 | url-status = dead }}</ref><ref name="dancesafe">{{cite web | url = http://www.dancesafe.org/drug-information/2c-b | title = 2C-B - Dancesafe.org | access-date = 2013-09-25 | publisher = [[Dancesafe]]}}</ref>

* At low doses, the experience may shift in intensity from engaging to mild/undetectable. Experienced users report the ability to take control of the effects and switch from engaged to sober at will.
* The hallucinations have a tendency to decrease and then increase in intensity, giving the users a sense of "waves" or even glowing. These are popularly described as "[[cliché]]d '70s visuals" or objects taking on "water color"-like textures.
* While the effects of the drug often render users unable to concentrate deeply on anything in particular, some can become engrossed in an activity such as watching a movie or playing a video game, thus distracting themselves from the visual and auditory effects of the drug.
* Excessive giggling or smiling is common, as is a tendency for deeper "belly laughs".
* Some users say that the effects are more intense when listening to music and report that they can [[Synesthesia|see sounds]] and noises.
* Some users experience a decrease in [[visual acuity]], although others report sharper vision.
* Through increased awareness of one's body, attention may be brought to perceived "imperfections" or internal body processes.{{break|2}}''The following effects are highly dose-dependent.''
* Open eye visuals (OEVs), such as cartoon-like distortions and red or green halos around objects. [[Closed-eye visualization|Closed eye visuals]] (CEVs) are more common than OEVs.
* Affects and alters ability to communicate, engage in deep thought, or maintain attention span.
* Some users report experiencing frightening or fearful effects during the experience. Users describe feeling frigid or cold on reaching a plateau, while others feel wrapped in comfortable blankets/ultimate pleasure.
* Coordination may be affected; some users lose balance or have perceptual distinction problems.
* Onset time of 2C-B is highly dose dependent, but usually from 45 to 75 minutes. Taken on a full stomach, the onset time is increased to two hours or more.
* Before it was scheduled, 2C-B was sold in small doses as an aphrodisiac {{crossreference|(see: {{slink||History}})}}. Some users report [[aphrodisiac]] effects at lower doses.<ref name="PiHKAL" /><ref name="Drugscope"/>{{break|2}}

Clinical studies in humans suggest that 2C-B is a psychedelic with some possible entactogen-like effects.<ref name="GonzálezTorrensFarré2015" /><ref name="PapaseitFarréPérez-Mañá2018" /><ref name="MallaroniMasonReckweg2023">{{cite journal | vauthors = Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KP, Ramaekers JG | title = Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition | journal = Clin Pharmacol Ther | volume = 114 | issue = 2 | pages = 423–433 | date = August 2023 | pmid = 37253161 | doi = 10.1002/cpt.2958 | url = }}</ref> Specific effects have included slight hallucinogenic states, perceptual changes, ego dissolution, time dilation, euphoria, feelings of well-being, reduced anger, increased reactivity to negative emotional stimuli, decreased ability to recognize expressions of happiness, augmented emotionality in speech, and mild sympathomimetic effects such as pressor effects, among others.<ref name="GonzálezTorrensFarré2015" /><ref name="PapaseitFarréPérez-Mañá2018" /><ref name="MallaroniMasonReckweg2023" />